Genetic Technologies (AU:GTG) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Genetic Technologies Limited has successfully completed the sale of its geneType business and assets to Rhythm Biosciences, marking a significant move in the genomic diagnostics sector. The transaction, finalized on December 23, 2024, involves a seamless transition with the support of both companies. This development reflects ongoing shifts in the market as companies adapt and restructure towards innovative growth.
For further insights into AU:GTG stock, check out TipRanks’ Stock Analysis page.